Q2 2019 Laboratory Corporation of America Holdings Earnings Call Transcript
Good day, ladies and gentlemen, and thank you for standing by. Welcome to the Q2 2019 LabCorp Earnings Conference Call. (Operator Instructions). As a reminder, this conference call is being recorded for replay purposes. It is now my pleasure to hand the conference over to, Ms. Clarissa Willett, VP of Investor Relations. Ma'am, you may begin.
Good morning and welcome to LabCorp's Second Quarter 2019 Conference Call. As detailed in today's press release, there will be a replay of this conference call available via telephone and Internet.
With me today are Dave King, Chairman and Chief Executive Officer; Glenn Eisenberg, Executive Vice President and Chief Financial Officer; and John Ratliff, CEO of Covance Drug Development.
This morning, in the Investor Relations section of our website at www.labcorp.com, we posted both our press release and Investor Relations presentation with additional information on our
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |